DNA & Genetics Qiagen Shares Rebound on Report It Is Assessing Strategic OptionsBy adminJanuary 25, 20260 Shares of Qiagen (NYSE: QGEN) this past week returned to trading in the $50 per-share range after three years mostly lumbering…
Microbiome AMP 25: Measles and Other Vaccine-Preventable Diseases Rebound in the Post-Pandemic EraBy adminNovember 15, 20250 Very sick five-year-old little boy fighting measles infection, boy is laying in bed under the blanket with an agonizing expression,…
